key: cord-0894712-89zoa0k2 authors: Pooventhiran, T.; Marondedze, Ephraim Felix; Govender, Penny Poomani; Bhattacharyya, Utsab; Rao, D. Jagadeeswara; Aazam, Elham S.; Kuthanapillil, Jinesh M.; E, Tomlal Jose; Thomas, Renjith title: Energy and reactivity profile and proton affinity analysis of rimegepant with special reference to its potential activity against SARS-CoV-2 virus proteins using molecular dynamics date: 2021-09-04 journal: J Mol Model DOI: 10.1007/s00894-021-04885-z sha: c96094b09a6fa553d27ca5ca6a140efddbb3114f doc_id: 894712 cord_uid: 89zoa0k2 Rimegepant is a new medicine developed for the management of chronic headache due to migraine. This manuscript is an attempt to study the various structural, physical, and chemical properties of the molecules. The molecule was optimized using B3LYP functional with 6-311G + (2d,p) basis set. Excited state properties of the compound were studied using CAM-B3LYP functional with same basis sets using IEFPCM model in methanol for the implicit solvent atmosphere. The various electronic descriptors helped to identify the reactivity behavior and stability. The compound is found to possess good nonlinear optical properties in the gas phase. The various intramolecular electronic delocalizations and non-covalent interactions were analyzed and explained. As the compound contain several heterocyclic nitrogen atoms, they have potential proton abstraction features, which was analyzed energetically. The most important result from this study is from the molecular docking analysis which indicates that rimegepant binds irreversibly with three established SARS-CoV-2 proteins with ID 6LU7, 6M03, and 6W63 with docking scores − 9.2988, − 8.3629, and − 9.5421 kcal/mol respectively. Further assessment of docked complexes with molecular dynamics simulations revealed that hydrophobic interactions, water bridges, and π–π interactions play a significant role in stabilizing the ligand within the binding region of respective proteins. MMGBSA-free energies further demonstrated that rimegepant is more stable when complexed with 6LU7 among the selected PDB models. As the pharmacology and pharmacokinetics of this molecule are already established, rimegepant can be considered as an ideal candidate with potential for use in the treatment of COVID patients after clinical studies. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00894-021-04885-z. Migraine is one of the major chronic disease affecting a large number of people throughout the globe [1] . Migraine reduces the quality of life and productivity, and limits the individual's participation in the social setup [2] . Usually, the migraine pain lasts between 4 and 72 h, and causes nausea, vomiting, irritation towards light, and sometimes phonophobia [3] . The calcitonin gene-related peptide (CGRP) receptor was found to have a typical role in the onset of migraine and small drug molecules and antibodies are developed to antagonize this receptor [4, 5] . Also, humanized antibodies against CGRP or its receptor are being used as a prophylaxis measure in the management of migraine [6] . Rimegepant was developed as a CGRP receptor by using Heck reaction, and Hayashi-Miyaura and Ellman reactions [7] . Rimegepant is a heterocyclic system where the cyclohexane ring system was designed with the help of Heck reaction. The other two reactions were used to design chiral centers with aryl and amine groups. This is a relatively new drug as it was marketed in 2020 as a small-molecule blocker of CGRP by the Biohaven Pharmaceuticals of New Haven, Connecticut [8] . SARS due to n-CoV-2 is at present considered as a global pandemic that affected the life and economy of all countries around the world [9, 10] . Vaccines have been developed to prevent this viral attack, but only a small fraction of the entire global population is fortunate enough to get them [11] [12] [13] . Once infected, it may cause serious effect on patients leading to SARS pneumonia and ultimately death. Even though drug development against this deadly disease is a matter of importance, new drug development is a timeconsuming process and hence, drug repurposing of existing drug molecules with known pharmacology and toxicity is a good idea. A lot of molecules are investigated as a probable candidate to treat the COVID related difficulties, but none of them is considered as a complete cure [14] [15] [16] [17] [18] [19] [20] . Computational methods have been extensively used for virtual screening and in silico screening of potential COVID-19 cures [21] [22] [23] . Remigepant is a newly marketed drug for the treatment of migraine. But its detailed electronic structure and reactivity are not reported elsewhere to the best of our knowledge. We used density functional theory to establish the structure and properties of the molecule. Also, we evaluated the intramolecular electron delocalizations, non-covalent interactions, and the average local ionization energy indices of the molecule. Also, we wanted to check whether this new drug is a probable candidate for drug repurposing for the management of the COVID-19. Jiang and co-workers already showed that this molecule is a potential inhibitor targeting 2′-O-ribose methyltransferase of SARS-CoV-2 [24] . In this manuscript, we report the structure and electronic features of this molecule and also molecular docking and molecular dynamics study of the compound was performed with three other established COVID protein targets. Rimegepant molecule was optimized with Gaussian-09 [25] software using DFT-B3LYP [26] functional and 6-311G + (2d,p) as a basis set. This optimized structure was used to study frontier molecular orbital (FMO) and nature bonding orbital (NBO). TD-DFT with RCAM-B3LYP [27] functional was used to simulate UV spectra and was visualized using GaussSum [28] . Rimegepant molecule has more than two reaction sites 1,2-difluorophenyl-, cycloheptapyrimidinamine-, piperidine-1-carboxylate-, and 2H-imidazopyridin-2-one groups. Reaction sites of rimegepant are calculated using Multiwavefunction [29] to prepare the electrostatic potential map [30] , ALIE, and noncovalent interactions [31] . Molecular docking was used to predict the binding affinity between the drug and different COVID − associated proteins, which was downloaded from the RCSB [32] . The COVID-2-related proteins used in this study are PDBs: 6LU7, 6M03, and 6W63. The first one with ID 6LU7 represents the crystal structure of the main protease Mpro protein of the n-CoV-2 [33] . 6MO3 is the COVID-19 main protease in apo form [34] and 6W63 is SARS coronavirus papain-like protease [35] . Docking was performed using Autodock Vina [36, 37] and visualized using BIOVA Discovery studio [38] and was confirmed using molecular dynamics simulations. Molecular dynamics simulations were executed using the GPU-accelerated Desmond software accessed through Schrodinger 2020 release 3 hosted by the Lengau Linux Cluster of the Centre for High Performance Computing South Africa [39, 40] . Before MD simulations, all models were downloaded from PDB and processed using the protein preparation wizard [40] available via the user interface Maestro version 12.5 [41] . Molecular dynamics simulation investigations were performed on undocked models (PDBs: 6LU7, 6M03, and 6W63) as well as their respective docked complexes for a timeframe of 400 ns. Before production, all systems were allowed to relax using the default conditions of DESMOND as given in Maestro. During the production stage, trajectories were recorded at 100-ps intervals. As a result, 4004 frames were recorded. All simulations used a TIP5P solvent model in a 10-Å orthorhombic box using OPLS3e as the force field [42] . Three sodium ions were added to both 6M03 and 6W63 whereas two sodium ions were added to 6LU7 systems to neutralize the positive charge and a physiological ion concentration of 0.15 M as NaCl was applied to using the system builder during the MD setup stage. An NPT ensemble utilizing 1 atm pressure and 300 K temperature was employed. Herein, the pressure and temperature were controlled using the Martyna-Tobias-Klein [43] and the Nose-Hoover chain thermostat methods respectively [43] . For barostat conditions, the isotropic coupling style was set for a relaxation time of 2 ps. No restraints were applied, and all the other parameters were kept at default. Reversible reference system propagator algorithms (RESPA) integrators with a timestep of 2 fs (2.00 for near bonded and 6.00 for far bonded) were utilized. A cut-off radius of 9 Å was used for both short-range electrostatic interactions such as Coulombic interactions and Van der Waals interactions. Long-range electrostatics were also treated with Particle Mesh Ewald (PME) using the default tolerance in Desmond. Post MD, various parameters such as protein-ligand interactions, root mean square deviation (RMSD), and root mean square fluctuation (RMSF), among others, were assessed. The Simulation Interaction Diagram tool available in Schrödinger Maestro was used for these parameters [41] . Rimegepant molecule structure was optimized by using density functional theory DFT-B3LYP as a method, and 6-311G + (2d,p) as a basis set. Figure 1 Rimegepant molecule structure was optimized by using density functional theory DFT-B3LYP as a method, and 6-311G + (2d,p) as a basis set. The frontier molecular orbitals (FMO) are mostly involved in reactions and explain the reactivity features of rimegepant [30, [44] [45] [46] [47] . Frontier molecular orbital data can be effectively used to study reactivity information. Table 1 explains those important chemical descriptors. The frontier molecular orbitals are higher occupied molecular orbital (HOMO) and lower unoccupied molecular orbital (LUMO) energies are − 6.5 and − 1.14 eV, Fig. 1 Optimized structure of rimegepant at B3LYP/6-311G + (2d,p) (blue color indicated nitrogen atoms, red-oxygen, black-carbon, greyhydrogen, and light blue-fluorine) respectively, and the energy gap between them is 5.36 eV. The gap is very high that the compound will remain as an organic insulator. The gas-phase ionization energy and electron affinity [49] are 6.5 and 1.14 eV respectively. The global hardness and softness energies for rimegepant are 2.68 and 0.37 respectively. The chemical potential [48] , electronegativity [30] , electrophilicity index [50] [51] [52] [53] , and nucleophilicity index [48] for rimegepant are − 3.82, 3.82, 2.73, and 0.37 eV, which indicates that the molecule is potentially reactive towards biological molecules. The calculated hardness and softness values are 2.68 and 0.37 [54] [55] [56] [57] [58] [59] [60] . Rimegepant molecule structure was optimized by using time-dependent density functional theory RCAMB3LYP as a method, 6-311G + (2d,p) as a basic set and methanol using as a solvent using the IEFPCM solvation model [35] [36] [37] . Figure 2 shows the UV-visible spectrum and Fig. 3 shows the orbitals involved in which the electronic transitions. Figure 2 shows the peak that appears at the wavelength is 260.05 nm and the oscillator strength is 03082. Figure 3 shows the important orbitals that participate in an electronic transition. The major peak was due to the transition of electrons from higher occupied molecular orbital (HOMO) to first lower unoccupied molecular orbital (LUMO + 1) which are located at 2H-imidazopyridin-2-one group to cycloheptapyridinamine group respectively with 91 percentage transition contribution. Intramolecular electron delocalizations due to hyperconjugation are very important for the stabilization of a molecule. Nature bonding orbitals (NBO) can be used as an ideal method for the evaluation of these type of interactions. NBO 3.1 suite [38] associated with the Gaussian09 W program was used to perform these calculations. The orbital occupancy and delocalization energy data helps to analyze the different electron shifts. Both bonding and anti-bonding orbitals for rimegepant can give details in this part by the transfer of electrons having suitable occupancies, from bonding, lone pairs, and anti-bonding orbitals to anti-bonding orbitals with absorbing some energy. The bonding electrons transfer from donor bonding orbitals to acceptor anti-bonding orbitals with their occupancies with suitable energies. From σ (N9-C23) with the occupancy 1.7135 to σ* (C22-C28) and σ* (C33-C34) with delocalization energies 13.63 and 25.61 kcal/mol respectively. From σ (N11-C29) with occupancy 1.7448 to σ* (C26-C32) and σ* (C37-C39) using the energies are 11.26 and 23. Molecular electrostatic potentials (MEP) explain the reaction sites that appear in a molecule [39] [40] [41] . Figure 4 shows the reaction sites of rimegepant molecule, within ± 18.98 Bohr 3 from the numerical value from − 1.000 to 0.100, and from blue to red in color. The blue color on primary amine nitrogen and nitrogen in cycloheptapyridinamine, carbonyl oxygen in piperidine-1-carboxylate, and 2H-imidazopyridine-2-one groups are electron-rich sites so electrophiles can easily attack these sites. The red color is for all the carbon having protons in 2H-imidazopyridine-2-one and piperidine-1-carboxylate, and carbon having protons and primary amine protons in cycloheptapyridinamine groups; these are electron-poor sites so nucleophiles can easily attack these sites. Rimegepant molecule was optimized by using density functional theory DFT-B3LYP as a method, and 6-311G + (2d,p) as a basis set. The average localized ionization energy (ALIE) can explain the resonance structure of the molecule, which also explains saturated and unsaturated bonds in the molecule, and its stability. Figure 5 shows the reaction sites of rimegepant molecule, within ± 19.07 Bohr 3 from the numerical value from 0.000 to 2.000, and from blue to red in color [42] [43] [44] . The blush-green color indicates the unsaturated or moving or delocalized electrons in rimegepant molecule, in 2H-imidazopyridine-2-one group, on amine nitrogen to carbon in cycloheptapyrinamine group, and in ring and fluorines to carbons in 1,2-difluorophenyl group; these areas are unsaturated or delocalized electrons sites so addition reactions can occur in these sites. The blue color is on all the protons in piperidine-1-carboxylate, cycloheptapyridinamide, and adjacent carbon in 2H-imidazopyridin-2-one groups; these sites are saturated single bond sites so substitution reactions can occur in these sites. Rimegepant molecule structure was optimized by using density functional theory DFT-B3LYP as a method, and 6-311G + (2d,p) as a basic set. The non-covalent interaction (NCI) property explains the non-covalent interaction but few types of bond attractions appear within the molecule, which are hydrogen, van der Waals, and steric type of forces [45] [46] [47] [48] . Figure 6 shows the non-covalent bond within rimegepant molecule, a graph-plotted energy against a reduced density gradient. The hydrogen bond appears the energy from − 0.198 to − 0.006 a.u. from fluorines to protons in the same 1,2-difluorophenyl and cycloheptapyridine groups. The van der Waals force of attractions are from carbonyl oxygen in 2H-imidazopyridin-2-one group to protons in piperidine-1-carboxylate group, and from oxygen in piperidine-1-carboxylate group to protons in the same group and protons in cycloheptapyridinamine group. The steric force of attractions is shown from 1,2-difluorophenyl group to cycloheptapyridinamine group, and from piperidine-1-carboxylate to 2H-imidazopyridin-2-one group. The rimegepant molecule, with its six nitrogen atoms, shows very high proton affinity. Due to the differences in the nature of the electronic environment, the proton affinities corresponding to the nitrogen atoms are different for different nitrogen atoms. Looking at the structure of the molecule, it can be seen that there is one nitrogen atom (N8) in the form of a free amine group attached to the cycloheptane ring, while there are two nitrogen atoms (N9 and N11) in the two pyridine rings. Again, one nitrogen atom (N6) can be observed as a constituent of the piperidine ring, while the imidazolone ring of the molecule contains two more nitrogen atoms (N7 and N10). An attempt was made to study the difference in proton affinity of the systems by estimating the enthalpy of protonation using the equation: Proton affinity (kcal/mole) Figure 7 graphically represents and compares all these six proton affinities. Figure 7 indicates that N8, i.e., the nitrogen atom of the free amine group, has the greatest proton affinity, followed by N9, i.e., the nitrogen atom of the pyridine ring, which is fused with the cycloheptane ring. Then comes N11, i.e., the nitrogen atom of the other pyridine ring, which is fused with the imidazolone ring, followed by N6, i.e., the nitrogen atom of the piperidine ring. N7 and N10, that are presented in the imidazolone ring, show comparatively less proton affinities. So, the order of the proton affinities of the six nitrogen atoms of the molecule becomes N8 > N9 > N11 > N6 > N7 > N10. N8 is the part of an isolated and independent amine group. It is the only nitrogen atom present in the rimegepant molecule that is not a part of any ring. So, the availability of the lone pair of electrons on it is not reduced by any electron withdrawing effect. This makes N8 have the highest proton affinity among the nitrogen atoms of the molecule. Then comes the nitrogen atoms of the pyridine rings N9 and N11 as the corresponding lone pairs of electrons do not participate in the resonance of the pyridine rings. The proton affinity of N9 is greater than that of N11, probably because, in the case of the latter, the corresponding pyridine ring is fused with an imidazolone ring, which pulls the electron cloud of the pyridine ring and makes the lone pair of electrons of N11 comparative less donatable than N7. The proton affinity of N6 is further less because of the conjugation of N6 with the attached -COOR group that reduces the availability of the lone pair of electrons on N6. The proton affinities of N7 and N10 are comparatively less than that of the rest of the nitrogen atoms, as these nitrogen atoms enjoy a cross conjugation with a carbonyl group. Protonation at any one of the nitrogen atoms between N7 and N11 is possible only at the cost of sacrificing this stabilizing cross conjugation. The proton affinity of N7 is slightly more than that of N10 probably as the former is attached to the piperidine ring that slightly increases the availability of the lone pair of electrons on it by + I effect. As the world is facing the severe pandemic COVID, we thought of assessing rimegepant's activity towards the known COVID proteins. We used molecular docking procedures for this study as mentioned in the methods section. This study gives biological activity information about the type of interactions between rimegepant and SARS-CoV-2 proteins (PDB IDs: 6LU7 [49] , 6M03, and 6W63 residues. Table S1 shows the docking results between rimegepant and SARS-CoV-2 proteins. The free energy of docking was found to be − 9.2, − 8.3, and − 9.5 kcal/mol respectively for the 6LU7, 6M03, and 6W63 systems. The free energy values are very high and hence we decided to investigate further. The score values 5740, 5764, and 6002 are rimegepant with SARS-CoV-2 proteins 6LU7, 6M03, and 6W63, respectively, surface areas are 667.40, 666.10, and 711.80 Ǻ 2 for rimegepant with SARS-CoV-2 proteins 6LU7, 6M03, and 6W63, respectively, and minimum atomic contact energies are − 280.28, − 265.46, and − 327.41 for rimegepant with SARS-CoV-2 proteins are 6LU7, 6M03, and 6W63 respectively. Table S2 represents different interactions between rimegepant and the proteins (6LU7, 6M03, and 6W63) while Fig. 8 gives a pictorial representation of interactions between drug and aminoacid residues [40, 48, [50] [51] [52] [53] . Table S3 shows the non-bond interactions between rimegepant with SARS-CoV-2 proteins (6LU7, 6M03, and 6W63). Root mean standard deviation (RMSD) fluctuations were used to assess if the protein-ligand had stabilized during the production stage. The results for the simulations of docked complexes are presented in Fig. 9 . For all the three protein-ligand complexes, equilibrium was attained at about 200 ns showing protein RMSD fluctuations of less than 2 Å. Close examination of all the three proteins (COVID-19 main protease synthetic construct with ID 6LU7, COVID-19 main protease apro form with ID 6M03, and main protease natural with PDB 6W63) showed no distortion of either the protein or docked ligand. Further assessment with protein root mean square fluctuations (RMSF) also confirmed that all the proteins were stable in their states. Examining the RMSF (Fig. 10) , the N-and C-terminals fluctuated more than other residues as expected. The other amino acids showed average fluctuations of less than 2.4 Å for docked 6LU7 and 6M03 while 6W63 had average fluctuations less than 2 Å. These findings demonstrate that all the three protein models were stable when docked with rimegepant over an MD timescale of 400 ns. Although there was a surge in rimegepant (6W63) RMSD at around 325 ns (Fig. 8c) , inspection of the trajectory revealed that the imidazolium side chain on the ligand was adjusting to a more stable position within the binding pocket [80] [81] [82] [83] [84] . Average protein-ligand interactions were computed from 250 ns to the last frame, the region in which all the complexes had equilibrated. The results are outlined in Fig. 11 below. On all models, hydrophobic interactions were found to be the primary forces for rimegepant binding onto the receptors. Residues such as HIS, MET, CYS, and LEU were among the major contributors to hydrophobic interactions as illustrated in Fig. 11 . For 6LU7, and 6M03, hydrophobic interactions between the ligand and protein residues HIS and MET were observed to occur more than 50% of the stipulated MD timeframe. GLN contributed significantly via H-bond interactions with rimegepant for than 100% of the MD production time particularly with 6LU7 and 6M03. Residues such as HIS, CYS, and THR also interacted with the ligand for at least 30% of the MD timeframe. Although similar interactions were noted on the receptor on 6W63, the residues involved were different. For example, with 6LU7 and 6M03, HIS offered both hydrophobic and H-bond interactions; whereas in 6W63, only hydrophobic interactions were observed, Furthermore, instead of direct H-bonding with GLN, water bridges appeared dominant and essential for ligand binding on 6W63. In addition to hydrophobic interactions, water bridges, predominantly with glutamine, also play a major role towards the binding of rimegepant to all the protein models. Lastly, pi-pi interactions, predominantly with histidine (HIS41), appeared to stabilize the docked complexes during the stipulated timeframe. Further investigation of binding strength on different proteins was performed using molecular mechanics generalized born surface area (MM/GBSA) calculations to predict the estimate binding free energies of rimegepant on the selected protein models. The MMGBSA module estimate binding free energy (∆G bind ) as a difference between the docked complex (∆G complex ) and the free receptor (∆G receptor ) and ligand (∆G ligand ) as shown below. For the individual components, the change in free energy for binding may be expressed as: (Table 2) represents combined electrostatics from lipophilic and packing contributions. The rest of the contributions such as Coulombic, H-bond, covalent, and Van der Waals interactions were listed individually. MM/GBSA energies were calculated from frame 2500 to frame 4000 where the system had equilibrated. The results are as presented in Table 2 . Although favorable binding is shown on all models, binding of rimegepant to PDB model 6LU7 appeared to be the most favored. In all models, van der Waals forces were the major contributors towards the binding energy. This is somewhat in agreement with our docking results where rimegepant and 6LU7 have higher full fitness, inter full fitness, solvent full fitness and better ΔG complex solvent polar than other two proteins. The results from frontier molecular analysis chemical descriptors of rimegepant were analyzed. NBO studies revealed the intensity of various intramolecular interactions. TD-DFT study of rimegepant explained the UV-visible spectral property, and major and minor contributions orbitals. The various wavefunction studies are MESP, ALIE, and NCI data that helped to predict the more than one reactivity and active site such as 1,2 difluorophenyl, cycloheptapyridinamine, piperidine-1-carboxylate, and 2H-imidazopyridin-2-one in rimegepant. Docking studies explained the ΔG, scores, minimum atomic contact energies, and different types of interactions between rimegepant and SARS-CoV-2 proteins. Time-dependent behaviors of docked complexes were investigated using molecular dynamics simulations over a time frame of 400 ns. Herein, intermolecular forces such as water bridges, π -π, and hydrophobic interactions were found to be the major contributors for ligand binding to receptor pocket. Estimate binding free energies using MMGBSA further demonstrated that rimegepant binding to the selected protein models (6LU7, 6M03, and 6W63) is favorable on all models with PDB 6LU7 being the most favored. It can be concluded that this compound may be investigated further for a potential medicine to act against the SARS-CoV-2. The online version contains supplementary material available at https:// doi. org/ 10. 1007/ s00894-021-04885-z. CGRP-Based migraine therapeutics: how might they work, why so safe, and what next? Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial The market for migraine drugs Distinct Patterns of internalization of different calcitonin gene-related peptide receptors Identification of small-molecule positive modulators of calcitonin-like receptor-based receptors Calcitonin gene-related peptidebeyond migraine prophylaxis Asymmetric synthesis of heterocyclic analogues of a CGRP receptor antagonist for treating migraine Rimegepant: first approval A pneumonia outbreak associated with a new coronavirus of probable bat origin What we know so far: COVID-19 current clinical knowledge and research COVID-19 Vaccine: a comprehensive status report COVID-19 coronavirus vaccine design using reverse vaccinology and machine learning COVID-19 vaccines: where we stand and challenges ahead Chloroquine for the 2019 novel coronavirus SARS-CoV-2 Chloroquine is a potent inhibitor of SARS coronavirus infection and spread Of chloroquine and COVID-19 New insights into the antiviral effects of chloroquine An update on current therapeutic drugs treating COVID-19 Arguments in favor of remdesivir for treating SARS-CoV-2 infections Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges Structural and physico-chemical evaluation of melatonin and its solution-state excited properties, with emphasis on its binding with novel coronavirus proteins Structural investigations, quantum mechanical studies on proton and metal affinity and biological activity predictions of selpercatinib Modelling the structural and reactivity landscapes of tucatinib with special reference to its wavefunction-dependent properties and screening for potential antiviral activity Structural analysis, virtual screening and molecular simulation to identify potential inhibitors targeting 2'-O-ribose methyltransferase of SARS-CoV-2 coronavirus Density functional theory A new hybrid exchange-correlation functional using the Coulomb-attenuating method (CAM-B3LYP) CCLIB: A library for package-independent computational chemistry algorithms Multiwfn: A multifunctional wavefunction analyzer Absolute hardness: companion parameter to absolute electronegativity Revealing noncovalent interactions RCSB Protein Data Bank: biological macromolecular structures enabling research and education in fundamental biology, biomedicine, biotechnology and energy Optimization of parameters for semiempirical methods I. Method Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors RCSB PDB -6W63: Structure of COVID-19 main protease bound to potent broad-spectrum non-covalent inhibitor X77 AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading Schrödinger Release 2019-3: Desmond Molecular Dynamics System Scalable algorithms for molecular dynamics simulations on commodity clusters OPLS3: A force field providing broad coverage of drug-like small molecules and proteins Constant pressure molecular dynamics algorithms Synthesis and spectroscopic study of three new oxadiazole derivatives with detailed computational evaluation of their reactivity and pharmaceutical potential Understanding reactivity of two newly synthetized imidazole derivatives by spectroscopic characterization and computational study Spectroscopic analysis and molecular docking of imidazole derivatives and investigation of its reactive properties by DFT and molecular dynamics simulations Molecular structure, spectroscopic, dielectric and thermal study, nonlinear optical properties, natural bond orbital, HOMO-LUMO and molecular docking analysis of (C6Cl2O4) (C10H14N2F)2·2H2O Applications of the conceptual density functional theory indices to organic chemistry reactivity Calculation of negative electron affinity and aqueous anion hardness using Kohn-Sham HOMO and LUMO energies Electrophilicity index Electrophilicity index within a conceptual DFT framework Electrophilicity index as a possible descriptor of biological activity Electrophilicity index Comparison of density functional and Hartree-Fock average local ionization energies on molecular surfaces Molecular electrostatic potentials: an effective tool for the elucidation of biochemical phenomena Average local ionization energies computed on the surfaces of some strained molecules The fundamental nature and role of the electrostatic potential in atoms and molecules An Occam's razor approach to chemical hardness: lex parsimoniae Average local ionization energy: a review Atomic and molecular energies in terms of electrostatic potentials at nuclei A new definition of cavities for the computation of solvation free energies by the polarizable continuum model Ab initio study of solvated molecules: a new implementation of the polarizable continuum model A Comprehensive comparison of the IEFPCM and SS(V)PE Continuum solvation methods with the COSMO approach Co-crystals of urea and hexanedioic acid with third-order nonlinear properties: an experimental and theoretical enquiry Spectroscopic and theoretical studies of potential anti-inflammatory polycyclic aromatic fluorophenyl substituted acyclic and heterocyclic analogues synthesized from 4,4'-difluorophenylchalcone Hybrid and bioactive cocrystals of pyrazinamide with hydroxybenzoic acids: detailed study of structure, spectroscopic characteristics, other potential applications and noncovalent interactions using SAPT Exploring the detailed spectroscopic characteristics, chemical and biological activity of two cyanopyrazine-2-carboxamide, derivatives using experimental and theoretical tools Time dependent density functional study on the electronic spectra of some derivatives of triafulvalene Synthesis and spectroscopic study of two new pyrazole derivatives with detailed computational evaluation of their reactivity and pharmaceutical potential ) α-methylation and α-fluorination electronic effects on the regioselectivity of carbonyl groups of uracil by H and triel bonds in the interaction of U, T and 5FU with HCl and TrH3 Quantum mechanical studies of three aromatic halogen-substituted bioactive sulfonamidobenzoxazole compounds with potential light harvesting properties Two neoteric pyrazole compounds as potential anti-cancer agents: synthesis, electronic structure, physico-chemical properties and docking analysis Theoretical studies on the structure and various physico-chemical and biological properties of a terphenyl derivative with immense antiprotozoan activity Structure, spectral features, bioactivity and light harvesting properties of methyl and dimethyl anthracene: experimental and first principle studies Cocrystals of pyrazinamide with p-toluenesulfonic and ferulic acids: DFT investigations and molecular docking studies Anti-cancerous brucine and colchicine: experimental and theoretical characterization Quantum mechanical and photovoltaic studies on the cocrystals of hydrochlorothiazide with isonazid and malonamide Theoretical studies into the spectral characteristics, biological activity, and photovoltaic cell efficiency of four new polycyclic aromatic chalcones Pharmacophore-based virtual screening and molecular docking to identify promising dual inhibitors of human acetylcholinesterase and butyrylcholinesterase Novel chalcones derivatives with potential antineoplastic activity investigated by docking and molecular dynamics simulations Molecular modeling approaches of selective adenosine receptor type 2A agonists as potential anti-inflammatory drugs Chemical composition, antimicrobial properties of siparuna guianensis essential oil and a molecular docking and dynamics molecular study of its major chemical constituent Identification of potential COX-2 inhibitors for the treatment of inflammatory diseases using molecular modeling approaches The authors would like to acknowledge the Faculty of Science: University of Johannesburg: Centre for Nanomaterials Science Research, Department of Chemical Sciences and the National Research Foundation (TTK170405225933) South Africa. The authors are also thankful to the Centre for High Performance Computing (CHPC) for computational resources.